Bacteria News and Research

RSS

Researchers discover how intestinal bacteria can influence blood glucose and lipid concentrations

Intestinal bacteria have attracted recent attention since they were discovered to influence various physiological functions and diseases in humans.

10 Apr 2018

DNA test method can help quickly prevent Legionnaires' outbreak

A DNA test method called polymerase chain reaction allowed New York City health officials to identify the source of a Legionnaires' disease outbreak within hours of specimen collection and should be considered in all Legionnaires' outbreak investigations, researchers say in the April issue of the Journal of Environmental Health.

10 Apr 2018

Validating the Diagnosis of Depression

It’s very difficult to diagnose depression. With depression, you can't open the brain to find answers, and the chemistry of the brain is separate from the chemistry of the body.

From Pittcon 10 Apr 2018

Nosopharm and UIC reveal pharmacology of new class of antibiotics to combat drug resistance

Nosopharm, a company dedicated to the research and development of new anti-infective drugs, and the University of Illinois at Chicago today announce the publication of a study in Molecular Cell on the mechanism of action of odilorhabdins, a new class of antibiotics to combat antibiotic resistance.

9 Apr 2018

Bacteria that make high energy tiny carbon rings

Scientists have now bred bacteria that can create microscopic high energy carbon rings. This scientific breakthrough comes from Caltech scientists who have tweaked the enzymes of these bacteria in ways so that they can provide new molecular structures.

9 Apr 2018

Using the Microbiome to Predict the Risk of Cirrhosis-Associated Hospitalization

The microbiome is the collection of microorganisms that colonize the human body. Dr. Jasmohan Bajaj discusses the relationship between the microorganisms in the gut and cirrhosis, and how microbiome analysis can be used to predict the risk of cirrhosis-associated hospitalizations.

7 Apr 2018

Research team identifies new class of antibiotics to fight drug resistance

Researchers from the University of Illinois at Chicago and Nosopharm, a biotechnology company based in Lyon, France, are part of an international team reporting on the discovery of a new class of antibiotics.

6 Apr 2018

Research reveals how bacteria prepare sticky adhesion protein

Researchers at Harvard Medical School, the University of California, San Francisco, and the University of Georgia have described how the protein that allows strep and staph bacteria to stick to human cells is prepared and packaged.

6 Apr 2018

Mice study reveals important role of pTreg cell population in autoimmune diabetes

In autoimmune diseases such as type 1 diabetes, some of the immune system's T cells mistakenly attack the body's own cells, while protective T regulatory cells try to defend against that attack.

6 Apr 2018

New point-of-care test accelerates diagnosis of Lyme neuroborreliosis

A new research-based point-of-care test has been developed in Finland for detecting the Lyme neuroborreliosis spread by ticks.

5 Apr 2018

New artificial enzyme uses visible light to kill bacteria

Researchers from RMIT University have developed a new artificial enzyme that uses light to kill bacteria.

5 Apr 2018

Germs that are near impossible to kill are on the rise warns CDC

Antibiotic resistance is on the rise and how! The Centers for Disease Control and Prevention (CDC), this week (3rd April 2018), released a warning that these bacteria that are near impossible to kill with the available antibiotics are on the rise.

5 Apr 2018

Microscopic revelations could lead to new treatment options for deadly blood infections

Researchers at the University of Calgary's Cumming School of Medicine (CSM) have for the first time been able to observe -- live and in real-time -- how the human body responds to often lethal fungal blood infections in the lung.

4 Apr 2018

Researchers reveal new tactic to fight antibiotic-resistant pneumonia

Antibiotic resistance is a growing threat in bacterial pneumonia. While immune-stimulating treatments can help the body kill the bacteria, they can also cause inflammation that damages and weakens lung tissue. Researchers at Boston Children's Hospital now describe an approach that offers the best of both worlds: enhanced bacterial killing with reduced lung damage.

4 Apr 2018

Photoswitchable drugs may light the way to treat disease with fewer side effects

Side effects from drugs working in non-target locations within the body can cause debilitating symptoms, often resulting in patients stopping their course of treatment early.

4 Apr 2018

Older Americans are hooked on vitamins despite scarce evidence they work

When she was a young physician, Dr. Martha Gulati noticed that many of her mentors were prescribing vitamin E and folic acid to patients. Preliminary studies in the early 1990s had linked both supplements to a lower risk of heart disease.

4 Apr 2018

‘Nightmare bacteria’ stalk U.S. hospitals

The Centers for Disease Control and Prevention detected more than 220 cases last year of a rare breed of "nightmare bacteria" that are virtually untreatable and capable of spreading genes that make them impervious to most antibiotics, according to a report released Tuesday.

3 Apr 2018

Gut bacteria may hold clues to predict effectiveness of cancer immunotherapies

The composition of bacteria in the gastrointestinal tract may hold clues to help predict which cancer patients are most apt to benefit from the personalized cellular therapies that have shown unprecedented promise in the fight against hard-to-treat cancers, according to new research from the Perelman School of Medicine at the University of Pennsylvania.

3 Apr 2018

Iowa State University researcher is searching for new way to fight superbugs

Vincenzo Venditti, an assistant professor of chemistry at Iowa State University, is searching for a new kind of antibiotic in the fight against superbugs.

2 Apr 2018

Combined treatment prolongs survival in mouse models of malignant mesothelioma

Combined treatment with two cancer immunotherapy drugs - one a novel immune modulator and one that focuses and activates the antitumor immune response - significantly prolonged survival in mouse models of the aggressive cancer malignant mesothelioma.

2 Apr 2018